On November 20, 2023, Checkpoint Therapeutics Inc (NASDAQ: CKPT) opened at $1.96, higher 8.33% from the last session. During the day, the shares moved up to $2.14 and dropped to $1.92 before settling in for the closing price of $1.92. Price fluctuations for CKPT have ranged from $1.30 to $8.15 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -17.75%. Company’s average yearly earnings per share was noted 57.83% at the time writing. With a float of $18.48 million, this company’s outstanding shares have now reached $21.59 million.
Let’s determine the extent of company efficiency that accounts for 24 employees.
Checkpoint Therapeutics Inc (CKPT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Checkpoint Therapeutics Inc is 14.40%, while institutional ownership is 18.14%. The most recent insider transaction that took place on Mar 02, was worth 27,415. In this transaction CEO, President and Director of this company sold 5,483 shares at a rate of $5.00, taking the stock ownership to the 144,090 shares. Before that another transaction happened on Mar 02, when Company’s Chief Financial Officer sold 3,591 for $5.00, making the entire transaction worth $17,955. This insider now owns 51,374 shares in total.
Checkpoint Therapeutics Inc (CKPT) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.29 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.76) by $0.47. This company achieved a net margin of -32616.67 while generating a return on equity of -1,220.38. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.83% per share during the next fiscal year.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators
Check out the current performance indicators for Checkpoint Therapeutics Inc (CKPT). In the past quarter, the stock posted a quick ratio of 0.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 264.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.27, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Checkpoint Therapeutics Inc (CKPT)
Looking closely at Checkpoint Therapeutics Inc (NASDAQ: CKPT), its last 5-days average volume was 0.37 million, which is a jump from its year-to-date volume of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 59.44%. Additionally, its Average True Range was 0.17.
During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 35.62%, which indicates a significant decrease from 86.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.25% in the past 14 days, which was lower than the 83.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8500, while its 200-day Moving Average is $2.7700. However, in the short run, Checkpoint Therapeutics Inc’s stock first resistance to watch stands at $2.1700. Second resistance stands at $2.2700. The third major resistance level sits at $2.3900. If the price goes on to break the first support level at $1.9500, it is likely to go to the next support level at $1.8300. Should the price break the second support level, the third support level stands at $1.7300.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats
There are currently 23,526K shares outstanding in the company with a market cap of 44.91 million. Presently, the company’s annual sales total 190 K according to its annual income of -62,620 K. Last quarter, the company’s sales amounted to 30 K and its income totaled -16,520 K.